This is a demo store. No orders will be fulfilled.

Cl-amidine TFA

PAD抑制剂
    级别和纯度:
  • ≥97%
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
C413918-5mg
5mg 现货 Stock Image
C413918-10mg
10mg 现货 Stock Image
C413918-25mg
25mg 现货 Stock Image
C413918-50mg
50mg 现货 Stock Image
C413918-100mg
100mg 现货 Stock Image

基本描述

别名 氯脒TFA
规格或纯度 ≥97%
英文名称 Cl-amidine TFA
生化机理 氯脒是一种不可逆的泛肽基精氨酸脱氨酶(PAD)抑制剂,对 PAD4、PAD1 和 PAD3 的 IC50 值分别为 5.9 ± 0.3 μM、0.8 ± 0.3 μM、6.2 ± 1.0 μM。氯脒诱导细胞凋亡。
储存温度 -20°C储存
运输条件 超低温冰袋运输
产品介绍


Information

Cl-amidine Cl-amidine is an irreversible pan- peptidylarginine deiminase (PAD) inhibitor with IC50 values of 5.9 ± 0.3 μM, 0.8 ± 0.3 μM, 6.2 ± 1.0 μM for PAD4, PAD1 and PAD3, respectively. Cl-amidine induces apoptosis .


Targets

PAD1 (Cell-free assay); PAD4 (Cell-free assay); PAD3 (Cell-free assay) 0.8 μM; 5.9 μM; 6.2 μM


In vitro

Cl-amidine antagonizes the PAD4-mediated enhancement of the the p300GBD-GRIP1 interaction in a dose-dependent manner. The inhibitory effect of this compound is not a nonspecific one but is targeted at the active PAD4 enzyme. Cl-amidine increases p53 expression in CD45 positive immune cells. It triggers the differentiation and apoptosis of multiple cancer cell lines that are p53+/+ and p53−/− (e.g., HL60, HT29, TK6, and U2-OS cells). Cl-amidine induces the expression of p53 and several downstream target genes including the cyclin dependent kinase inhibitor p21, GADD45, and the proapoptotic protein PUMA in U2-OS osteosarcoma cells.


In vivo

Cl-amidine treatment inhibits NZM(New Zealand mixed 2328) NET(neutrophil extracellular trap) formation in vivo and significantly alters circulating autoantibody profiles and complement levels while reducing glomerular IgG deposition. Further, Cl-amidine increases the differentiation capacity of bone marrow endothelial progenitor cells, improves endothelium-dependent vasorelaxation, and markedly delays time to arterial thrombosis induced by photochemical injury. Cl-amidine delays thrombosis development in NZM mice. It inhibits PADs in mice without significant toxicity and improves disease phenotypes in animal models of inflammatory arthritis and inflammatory bowel disease. And It is shown to reduce disease severity in mouse models of ulcerative colitis and RA.


Cell Research(from reference)

Cell lines:CV-1 cells 

Concentrations:0-200 μM 

Incubation Time:40 h 

纯度 ≥97%

产品属性

ALogP 1.333
hba_count 3
HBD Count 3
Rotatable Bond 10

关联靶点(人)

PADI1 Tchem 1 型蛋白质精氨酸脱亚胺酶(Protein-arginine deiminase type-1) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
HL-60 (67320 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PADI4 Tchem Protein-arginine deiminase type-4 (309 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PADI1 Tchem Protein-arginine deiminase type-1 (130 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PADI2 Tchem Protein-arginine deiminase type-2 (138 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PADI3 Tchem Protein-arginine deiminase type-3 (118 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

名称和识别符

分子类型 小分子
IIUPAC Name N-[(2S)-1-amino-5-[(1-amino-2-chloroethylidene)amino]-1-oxopentan-2-yl]benzamide;2,2,2-trifluoroacetic acid
INCHI 1S/C14H19ClN4O2.C2HF3O2/c15-9-12(16)18-8-4-7-11(13(17)20)19-14(21)10-5-2-1-3-6-10;3-2(4,5)1(6)7/h1-3,5-6,11H,4,7-9H2,(H2,16,18)(H2,17,20)(H,19,21);(H,6,7)/t11-;/m0./s1
InChi Key WUSNMVYWOLUWDD-MERQFXBCSA-N
Smiles C1=CC=C(C=C1)C(=O)NC(CCCN=C(CCl)N)C(=O)N.C(=O)(C(F)(F)F)O
Isomeric SMILES C1=CC=C(C=C1)C(=O)N[C@@H](CCCN=C(CCl)N)C(=O)N.C(=O)(C(F)(F)F)O
关联CAS 1373232-26-8;913723-61-2
分子量 424.8

化学和物理性质

溶解性 Solubility (25°C) In vitro DMSO: 84 mg/mL warmed with 50ºC Water: bath (197.74 mM); Ethanol: 84 mg/mL warmed with 50ºC Water: bath (197.74 mM); Water: 70 mg/mL warmed with 50ºC Water: bath (164.78 mM);
DMSO(mg / mL) Max Solubility 84
DMSO(mM) Max Solubility 197.740113
Water(mg / mL) Max Solubility 70
Water(mM) Max Solubility 164.7834275
分子量 424.800 g/mol
XLogP3
氢键供体数Hydrogen Bond Donor Count 4
氢键受体数Hydrogen Bond Acceptor Count 8
可旋转键计数Rotatable Bond Count 8
精确质量Exact Mass 424.113 Da
单同位素质量Monoisotopic Mass 424.113 Da
拓扑极表面积Topological Polar Surface Area 148.000 Ų
重原子数Heavy Atom Count 28
形式电荷Formal Charge 0
复杂度Complexity 465.000
同位素原子数Isotope Atom Count 0
定义的原子立体中心计数Defined Atom Stereocenter Count 1
未定义的原子立体中心计数Undefined Atom Stereocenter Count 0
定义的键立体中心计数Defined Bond Stereocenter Count 0
未定义的键立体中心计数Undefined Bond Stereocenter Count 0
所有立体化学键的总数The total count of all stereochemical bonds 0
共价键合单元计数Covalently-Bonded Unit Count 2

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到12个结果

批号(Lot Number) 证书类型 货号
I2404295 分析证书 C413918
I2404296 分析证书 C413918
D2312924 分析证书 C413918
D2312942 分析证书 C413918
D2312945 分析证书 C413918
D2312946 分析证书 C413918
D2312958 分析证书 C413918
D2312959 分析证书 C413918
D2312961 分析证书 C413918
D2312977 分析证书 C413918
D2312986 分析证书 C413918
D23121012 分析证书 C413918

显示更多⌵

溶液计算器